Home LiteratureArticle Details
PMID: 7969161 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins.

Molecular and cellular biology ·Vol. 14 ·No. 12 ·1994-12-00 ·Pages 8241-9

Melillo RM, Helin K, Lowy DR, Schiller JT

Abstract

E2F-1 is a member of a family of transcription factors implicated in the activation of genes required for the progression through the S phase of the cell cycle. We have examined the biological activities of E2F-1 with short-term colony-forming assays and long-term immortalization assays. High levels of E2F-1, produced by transfection of the E2F-1 cDNA under the control of a strong promoter, reduced colony formation in normal human foreskin keratinocytes (NHFKs). This inhibition could not be overcome by wild-type human papillomavirus type 16 (HPV16) E6 and E7, two proteins which cooperate to immortalize NHFKs, or by a transdominant p53 mutant. High levels of E2F-1 also inhibited growth of primary and established fibroblasts. The growth-inhibitory activity required the DNA binding function of E2F-1 but not its transactivation or pRB binding activities. A positive role for lower levels of E2F-1 in NHFK immortalization was established by examining the ability of E2F-1 to complement HPV16 E7 mutants that were unable to cooperate with HPV16 E6 to immortalize NHFKs. Although E2F-1 was unable by itself to cooperate with E6, it did, in conjunction with E6, complement a p24GLY mutant of E7 that is defective for immortalization and binding of pRB and pRB-related proteins. By contrast, E2F-1 was unable to complement two other E7 mutants, p2PRO and p31/32ARG/PRO, which are also defective in the immortalization assay, although their proteins display wild-type binding of pRB in vitro. Since the binding of E7 to pRB results in disruption of pRB-E2F interaction and release of transcriptionally active E2F, the data support the hypothesis that binding of pRB by E7 and the consequence increase in E2F, the data support the hypothesis that binding of pRB by E7 and the consequence increase in E3F activity are important but not sufficient for E7-induced keratinocyte immortalization.

Related Genes
MeSH Terms
3T3 Cells Animals Carrier Proteins Cell Cycle Proteins Cell Division Cell Transformation, Neoplastic Cell Transformation, Viral DNA-Binding Proteins/metabolism E2F Transcription Factors E2F1 Transcription Factor Genetic Complementation Test Humans In Vitro Techniques Keratinocytes/cytology Male Mice Oncogene Proteins, Viral/physiology Papillomaviridae Papillomavirus E7 Proteins Repressor Proteins Retinoblastoma Protein/metabolism Retinoblastoma-Binding Protein 1 Transcription Factor DP1 Transcription Factors/physiology Zinc Fingers
Chemicals
Arid4a protein, mouse Carrier Proteins Cell Cycle Proteins DNA-Binding Proteins E2F Transcription Factors E2F1 Transcription Factor E2F1 protein, human E2f1 protein, mouse E6 protein, Human papillomavirus type 16 Oncogene Proteins, Viral Papillomavirus E7 Proteins Repressor Proteins Retinoblastoma Protein Retinoblastoma-Binding Protein 1 Transcription Factor DP1 Transcription Factors oncogene protein E7, Human papillomavirus type 16
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Melillo R M
Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland 20892.
Helin K
Lowy D R
Schiller J T
References (58)
58 references, click to expand
  1. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.
    Genes Dev. 1993 Jul;7(7A):1111-25 PMID: 8319904
  2. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.
    EMBO J. 1990 Jan;9(1):153-60 PMID: 2153075
  3. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation.
    Cell. 1990 Aug 24;62(4):659-69 PMID: 2143697
  4. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
    Genes Dev. 1993 Aug;7(8):1559-71 PMID: 8339933
  5. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation.
    Genes Dev. 1993 Oct;7(10):1850-61 PMID: 8405995
  6. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.
    Cell. 1988 May 20;53(4):539-47 PMID: 2836062
  7. HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.
    EMBO J. 1994 Feb 15;13(4):871-8 PMID: 8112300
  8. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.
    Cell. 1992 Jul 24;70(2):337-50 PMID: 1638634
  9. Viruses in human cancers.
    Science. 1991 Nov 22;254(5035):1167-73 PMID: 1659743
  10. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein.
    J Virol. 1992 Apr;66(4):2418-27 PMID: 1312637
  11. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F.
    Mol Cell Biol. 1992 Dec;12(12):5620-31 PMID: 1448092
  12. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation.
    J Virol. 1993 May;67(5):2521-8 PMID: 8386265
  13. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.
    J Virol. 1989 Oct;63(10):4417-21 PMID: 2476573
  14. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex.
    Mol Cell Biol. 1993 Oct;13(10):6537-46 PMID: 8413252
  15. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner.
    Cell. 1992 Jan 10;68(1):157-66 PMID: 1531040
  16. Cell cycle-specific association of E2F with the p130 E1A-binding protein.
    Genes Dev. 1993 Dec;7(12A):2392-404 PMID: 8253385
  17. Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding.
    J Virol. 1993 Jun;67(6):3142-50 PMID: 8497045
  18. Death-defying acts: a meeting review on apoptosis.
    Genes Dev. 1993 Dec;7(12A):2277-84 PMID: 7902825
  19. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18.
    J Virol. 1990 Feb;64(2):519-26 PMID: 2153221
  20. Human papillomavirus type 16 E7 regulates E2F and contributes to mitogenic signalling.
    Oncogene. 1993 Apr;8(4):893-8 PMID: 8455943
  21. The retinoblastoma protein as a transcriptional repressor.
    Trends Cell Biol. 1993 Feb;3(2):43-6 PMID: 14731718
  22. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein.
    J Biol Chem. 1994 Mar 4;269(9):6842-50 PMID: 8120046
  23. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes.
    EMBO J. 1986 Sep;5(9):2285-92 PMID: 3023067
  24. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4549-53 PMID: 1316611
  25. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells.
    Oncogene. 1990 Sep;5(9):1383-9 PMID: 2216461
  26. p53 and E2F-1 cooperate to mediate apoptosis.
    Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3602-6 PMID: 8170954
  27. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.
    Cell. 1992 Jul 24;70(2):351-64 PMID: 1638635
  28. A binding site for transcription factor E2F is a target for trans activation of murine thymidine kinase by polyomavirus large T antigen and plays an important role in growth regulation of the gene.
    J Virol. 1993 Apr;67(4):1765-71 PMID: 8445710
  29. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
    Oncogene. 1992 Sep;7(9):1681-6 PMID: 1323816
  30. The E2F transcription factor is a cellular target for the RB protein.
    Cell. 1991 Jun 14;65(6):1053-61 PMID: 1828392
  31. A point mutational analysis of human papillomavirus type 16 E7 protein.
    J Virol. 1989 Jun;63(6):2650-6 PMID: 2542578
  32. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes.
    FASEB J. 1993 Jul;7(10):872-9 PMID: 8393818
  33. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.
    J Virol. 1992 Jul;66(7):4201-8 PMID: 1318401
  34. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein.
    Mol Cell Biol. 1993 Oct;13(10):6501-8 PMID: 8413249
  35. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control.
    Trends Biochem Sci. 1994 Mar;19(3):108-14 PMID: 8203017
  36. Papillomavirus polypeptides E6 and E7 are zinc-binding proteins.
    J Virol. 1989 Mar;63(3):1404-7 PMID: 2536841
  37. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.
    EMBO J. 1989 Dec 1;8(12):3905-10 PMID: 2555178
  38. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.
    Cell. 1993 Nov 5;75(3):495-505 PMID: 8221889
  39. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.
    EMBO J. 1989 Dec 20;8(13):4099-105 PMID: 2556261
  40. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes.
    J Virol. 1993 Aug;67(8):4521-32 PMID: 8392596
  41. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes.
    J Virol. 1992 Mar;66(3):1329-35 PMID: 1310752
  42. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F.
    EMBO J. 1993 Nov;12(11):4317-24 PMID: 8223441
  43. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A.
    Cell. 1991 Jun 28;65(7):1243-53 PMID: 1829647
  44. Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein.
    J Virol. 1994 Aug;68(8):5027-35 PMID: 8035503
  45. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes.
    J Virol. 1992 Oct;66(10):6237-41 PMID: 1326671
  46. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.
    Nature. 1992 Jan 9;355(6356):176-9 PMID: 1530885
  47. Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1.
    J Virol. 1993 Dec;67(12):7641-7 PMID: 8230483
  48. The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F.
    Cell. 1991 Jun 14;65(6):1063-72 PMID: 1828393
  49. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product.
    Science. 1989 Feb 17;243(4893):934-7 PMID: 2537532
  50. Negative charge at the casein kinase II phosphorylation site is important for transformation but not for Rb protein binding by the E7 protein of human papillomavirus type 16.
    Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5187-91 PMID: 2052600
  51. A new component of the transcription factor DRTF1/E2F.
    Nature. 1993 Mar 4;362(6415):83-7 PMID: 8446173
  52. Expression of transcription factor E2F1 induces quiescent cells to enter S phase.
    Nature. 1993 Sep 23;365(6444):349-52 PMID: 8377827
  53. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4.
    Mol Cell Biol. 1993 Oct;13(10):6314-25 PMID: 8413230
  54. Cyclin A and the retinoblastoma gene product complex with a common transcription factor.
    Nature. 1991 Jul 18;352(6332):249-51 PMID: 1830372
  55. Suppression of human colorectal carcinoma cell growth by wild-type p53.
    Science. 1990 Aug 24;249(4971):912-5 PMID: 2144057
  56. Identification of a cellular transcription factor involved in E1A trans-activation.
    Cell. 1986 Apr 25;45(2):219-28 PMID: 2938741
  57. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein.
    Cell. 1991 Jun 14;65(6):1073-82 PMID: 1828394
  58. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein.
    Proc Natl Acad Sci U S A. 1986 Jul;83(13):4680-4 PMID: 3014503
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1994-12-00
Pages
8241-9
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC359363
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com